XML 52 R15.htm IDEA: XBRL DOCUMENT v3.20.1
Stock Based Compensation
12 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]  
STOCK BASED COMPENSATION

NOTE 9 – STOCK BASED COMPENSATION

 

In January 2018, the Company's board of directors approved its 2018 Stock Incentive Plan ("2018 Plan"). The 2018 Plan provides for the grant of non-qualified stock options and incentive stock options to purchase shares of the Company's common stock, the grant of restricted and unrestricted share awards and grant of restricted stock units. The 2018 Plan provides for the issuance of 1,630,000 shares of common stock. All of the Company's employees and any subsidiary employees (including officers and directors who are also employees), as well as all of the Company's nonemployee directors and other consultants, advisors and other persons who provide services to the Company will be eligible to receive incentive awards under the 2018 Plan.

 

The following table summarizes the stock-based compensation expense recorded in the Company's results of operations during the years ended December 31, 2019 and 2018 for stock options and warrants:

 

   Year Ended   Period from January 24,
2018
(inception) to
 
   December 31,
2019
   December 31,
2018
 
Research and development  $   $ 
General and administrative   590,041    1,329,074 
   $590,041   $1,329,074 

 

As of December 31, 2019, there was approximately $3,940,461 of total unrecognized compensation expense related to non-vested share-based compensation arrangements that are expected to vest. This cost is expected to be recognized over a weighted-average period of 3.1 years.

 

The Company records compensation expense for employee awards with graded vesting using the straight-line method. The Company records compensation expense for nonemployee awards with graded vesting using the accelerated expense attribution method. The Company recognizes compensation expense over the requisite service period applicable to each individual award, which generally equals the vesting term. The Company estimates the fair value of each option award using the Black-Scholes-Merton option pricing model. Forfeitures are recognized when realized.

 

The Company estimated the fair value of employee and non-employee stock options using the Black-Scholes option pricing model. The fair value of employee stock options is being amortized on a straight-line basis over the requisite service periods of the respective awards. The fair value of employee stock options issued was estimated using the following weighted-average assumptions:

 

   Year Ended
December 31,
2019
   Year Ended
December 31,
2018
 
Weighted average exercise price  $4.42   $2.50 
Weighted average grant date fair value  $3.08   $1.21 
Assumptions          
Expected volatility   88-90%   92.24%
Weighted average expected term (in years)   6.3    6.26 
Risk-free interest rate   1.68-2.31%   2.93%
Expected dividend yield   0.00%   0.00%

 

The risk-free interest rate was obtained from U.S. Treasury rates for the applicable periods. The Company's expected volatility was based upon the historical volatility for industry peers and used an average of those volatilities. The expected life of the Company's options was determined using the simplified method as a result of limited historical data regarding the Company's activity. The dividend yield considers that the Company has not historically paid dividends, and does not expect to pay dividends in the foreseeable future.

 

For grants prior to the IPO, the fair value of the common stock was determined by the board of directors based on a variety of factors, including valuations prepared by third parties, the Company's financial position, the status of development efforts within the Company, the current climate in the marketplace and the prospects of a liquidity event, among others. For grants after the IPO, the Company uses the closing stock price on the date of grant as the fair value of the common stock.

 

The following table summarizes stock option activity during the periods ended December 31, 2019 and 2018:

 

   Number of Shares   Weighted-
Average
Exercise
Prices
   Weighted-
Average
Remaining
Contractual
Term (In Years)
   Intrinsic Value 
Outstanding at January 1, 2018      $       $ 
Granted   1,073,082    2.50         
Outstanding at December 31, 2018   1,073,082    2.50    9.64   $ 
Granted   1,065,996    4.42         
Outstanding at December 31, 2019   2,139,078   $3.46    9.17   $4,052,512 
Exercisable at December 31, 2019   470,000   $2.62    8.71   $1,283,560